TriSalus (TLSI) director receives RSU and stock option grants
Rhea-AI Filing Summary
TriSalus Life Sciences director Gary B. Gordon received equity awards in the form of common stock and stock options. The filing reports grants of 24,553 and 28,201 shares of common stock at a price of $0.00 per share, reflecting restricted stock unit awards.
One RSU award fully vests on the one-year anniversary of the grant date of May 14, 2026, while a separate retainer RSU award vests in three equal quarterly installments through the remainder of 2026, in lieu of cash board fees. In addition, Gordon received a director stock option covering 56,403 shares of common stock at an exercise price of $2.52 per share, expiring in 2036, which also fully vests on the one-year anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 52,754 shares
Net Buy
3 txns
Insider
Gordon Gary B.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 56,403 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 28,201 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 24,553 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Option (right to buy) — 112,653 shares (Direct);
Common Stock — 62,510 shares (Direct)
Footnotes (3)
- F1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
- F2. Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
- F3. The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
Key Figures
RSU award 1: 24,553 shares
RSU award 2: 28,201 shares
Director stock option size: 56,403 shares
+3 more
6 metrics
RSU award 1
24,553 shares
Restricted stock unit award in common stock
RSU award 2
28,201 shares
Retainer RSU award in lieu of 2026 cash board fees
Director stock option size
56,403 shares
Underlying common shares for director stock option grant
Option exercise price
$2.52 per share
Conversion or exercise price for director stock option
Option expiration
2036-05-13
Expiration date of director stock option grant
Common shares price
$0.00 per share
Transaction price for RSU-based common stock grants
Key Terms
restricted stock units, Retainer RSU Award, Non-Employee Director Compensation Policy, Director Stock Option, +1 more
5 terms
restricted stock units financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Retainer RSU Award financial
"Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock"
Non-Employee Director Compensation Policy financial
"in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy"
Director Stock Option financial
"Director Stock Option (right to buy)"
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did TriSalus (TLSI) director Gary B. Gordon report?
Gary B. Gordon reported equity awards, not open-market trades. He received 24,553 and 28,201 common shares via restricted stock unit grants, plus a director stock option for 56,403 underlying common shares at a fixed exercise price.
Were Gary B. Gordon’s TLSI Form 4 transactions stock purchases or compensation grants?
The transactions are compensation-related grants, not market purchases. All three entries use code A for grants or awards, with a per-share transaction price of $0.00, indicating equity compensation rather than cash-funded buying in the open market.
How do the TriSalus (TLSI) RSU awards to Gary B. Gordon vest?
One RSU award fully vests on the one-year anniversary of the grant date of May 14, 2026. A separate retainer RSU award vests quarterly in equal one-third installments through the remainder of 2026, contingent on continued board service.
What are the key terms of Gary B. Gordon’s TLSI director stock option grant?
The director stock option covers 56,403 underlying common shares at a $2.52 exercise price. The option fully vests on the one-year anniversary of the May 14, 2026 grant date and carries an expiration date in 2036, subject to continued service.
Does Gary B. Gordon’s TLSI Form 4 indicate any stock sales or disposals?
The Form 4 shows no sales or disposals. All transactions are coded A, reflecting grants or awards that increase his equity exposure, with transaction_direction labeled as acquire and no sell or dispose transactions reported.